1. Home
  2. CMC vs SRRK Comparison

CMC vs SRRK Comparison

Compare CMC & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Metals Company

CMC

Commercial Metals Company

HOLD

Current Price

$65.70

Market Cap

6.8B

Sector

Industrials

ML Signal

HOLD

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$49.56

Market Cap

5.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMC
SRRK
Founded
1915
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.8B
5.6B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
CMC
SRRK
Price
$65.70
$49.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
12
Target Price
$73.89
$55.64
AVG Volume (30 Days)
1.2M
1.7M
Earning Date
03-26-2026
05-13-2026
Dividend Yield
1.21%
N/A
EPS Growth
N/A
N/A
EPS
2.41
N/A
Revenue
$7,918,430,000.00
N/A
Revenue This Year
$18.81
N/A
Revenue Next Year
$6.82
$544.77
P/E Ratio
$27.45
N/A
Revenue Growth
25.57
N/A
52 Week Low
$41.17
$27.07
52 Week High
$84.87
$51.63

Technical Indicators

Market Signals
Indicator
CMC
SRRK
Relative Strength Index (RSI) 53.41 59.51
Support Level $56.26 $42.52
Resistance Level $71.99 N/A
Average True Range (ATR) 2.13 2.10
MACD 1.09 0.41
Stochastic Oscillator 87.15 79.15

Price Performance

Historical Comparison
CMC
SRRK

About CMC Commercial Metals Company

Commercial Metals Co is a manufacturer and supplier of early-stage construction materials, including steel reinforcing bars, concrete pipes, precast products, and soil stabilization solutions. It also produces merchant bar, steel fence posts, and wire rod, serving domestic and some international markets in Europe and Asia. Its products are used in infrastructure and building projects such as highways, bridges, airports, and commercial and residential buildings.

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

Share on Social Networks: